IL6R: Interleukin-6 receptor subunit alpha
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Part of the receptor for interleukin 6.
- Drugs that act on it: 4
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US drug page link to it| Sarilumab | Approved | Interleukin-6 receptor alpha subunit antagonist | Antagonist | Boxed warning |
| Levilimab | — | Interleukin-6 receptor alpha subunit inhibitor | Inhibitor | — |
| Tocilizumab | — | Interleukin-6 receptor alpha subunit inhibitor | Inhibitor | Boxed warning |
| Vobarilizumab | — | Interleukin-6 receptor alpha subunit inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Atopic eczema
- 0.70
- Coronary artery disorder
- 0.60
- Temporal arteritis
- 0.58
- Asthma
- 0.58
- Hyper-IgE recurrent infection syndrome 5, autosomal recessive
- 0.57
- Dermatitis
- 0.57
- Abdominal aortic aneurysm
- 0.55
- Immune system disorder
- 0.53
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- IL6R
- Related
- IL6Ralpha/GP130
Drugs and mechanisms are from ChEMBL CHEMBL2364155 (CC BY-SA 3.0). Gene name, function (UniProt P08887, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets